Cargando…
Analytical considerations for reducing the matrix effect for the sphingolipidome quantification in whole blood
AIM: Plasma and serum are widely used blood-derived biofluids for metabolomics and lipidomics assays, but analytes that are present in high concentrations in blood cells cannot be evaluated in those samples and isolating serum or plasma could introduce additional variability in the data. MATERIALS &...
Autores principales: | Wang, Dezhen, Xu, Peining, Mesaros, Clementina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Newlands Press Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240607/ https://www.ncbi.nlm.nih.gov/pubmed/34110924 http://dx.doi.org/10.4155/bio-2021-0098 |
Ejemplares similares
-
Sphingolipidomics in Translational Sepsis Research–Biomedical Considerations and Perspectives
por: Claus, Ralf A., et al.
Publicado: (2021) -
Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity
por: Hammad, Samar M., et al.
Publicado: (2019) -
Development and validation of a clinical HPLC method for the quantification of hydroxychloroquine and its metabolites in whole blood
por: Qu, Ying, et al.
Publicado: (2015) -
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
por: Merrill, Alfred H.
Publicado: (2011) -
An Update on Sphingolipidomics: Is Something Still Missing? Some Considerations on the Analysis of Complex Sphingolipids and Free-Sphingoid Bases in Plasma and Red Blood Cells
por: Morano, Camillo, et al.
Publicado: (2022)